CLNN
Closed
Clene Inc.
3.9
0.0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 3.91
Day's Range: 3.84 - 4.09
Send
sign up or login to leave a comment!
When Written:
1.13
Clene Inc. is a clinical-stage biopharmaceutical company that specializes in developing therapies for neurodegenerative diseases. The company's focus is on developing nanotechnology-based therapeutics that can target and repair damaged neurons in the brain and central nervous system. Clene's lead product candidate, CNM-Au8, is a gold nanocrystal suspension that has shown promising results in preclinical studies for treating multiple sclerosis, Parkinson's disease, and other neurodegenerative disorders. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








